Geisinger Medical Laboratories Test Catalog
JO-1 MYOSITIS PANEL |
||
ORDERING INFORMATION: |
Geisinger Epic Procedure Code: LAB2736 Geisinger Epic ID: 41284 | |
SPECIMEN COLLECTION |
||
Specimen type: |
Serum | |
Preferred collection container: |
||
Specimen required: |
One 0.5 mL aliquot from the SST AND two 3.0 mL aliquots from the plain red-top tubes. | |
Special notes: |
Collect one (1) serum separator tube (SST) for tests performed at GMC Immunology AND two (2) non-serum separator (plain) tubes for additional tests sent to Quest Diagnostics. | |
SPECIMEN PROCESSING |
||
Specimen processing instructions: |
Allow to clot. Centrifuge and submit one 0.5 mL aliquot from the SST and two 3.0 mL aliquots from the plain red-top tubes. | |
Transport temperature: |
Refrigerated (preferred). Room temperature (stable 8 hours) and frozen specimens also acceptable. | |
Specimen stability: |
Room temperature: 8 hours; 2-8 C: 48 hours. Frozen: 6 months. The sendout testing to Quest is stable 14 days refrigerated. | |
Rejection criteria: |
Specimen stability exceeded; specimen grossly hemolyzed. | |
TEST DETAILS |
||
Reference interval: |
Negative. | |
Additional information: |
The JO1 antibody testing is performed in the Immunopathology Laboratory at GMC Danville campus. Additional tests for myositis are sent to Quest Diagnostics. | |
CPT code(s): |
86235 x3 83516 x5 | |
Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Test includes: |
Antibody testing for JO1, PL-7, PL-12, Mi-2, Ku, EJ, OJ, SRP. | |
Methodology: |
Enzyme Immunoassay (EIA) Radioimmunopreciptation assay (RIPA) |
|
Synonyms: |
Myositis panel JO1 with reflex myositis JO1RM
|
|
Clinical significance: |
A positive JO1 antibody can be used in conjunction with other laboratory tests and clinical findings to aid in the diagnosis of polymyositis and other related connective diseases. | |
Doctoral Director(s:) |
Hoi-Ying Elsie Yu PhD, DABCC | |
Review Date: | 12/13/2022 |